Director, Life Cycle Management (Hematology)

Build our future together: The Director, Global Life Cycle Management (LCM) Lead for Hematology is a member of the Hematology Portfolio team within the Oncology Business Unit and is responsible for driving life cycle management strategy and forward-looking planning for the brand, in alignment with the broader brand strategy and hematology development program. This role will play a critical part in ensuring a holistic and integrated view of the program, with a focus on future commercial opportunities across earlier lines of multiple myeloma (including 1L), as well as expansion into plasma cell dyscrasias such as MGUS, SMM, and amyloidosis. As a strategic, cross-functional leader, this individual evaluates competitive dynamics and emerging treatment paradigms to optimize the long-term value of the asset, serving as a key bridge between the clinical development roadmap and brand strategy evolution. The role also provides strategic input and recommendations to the SPT and commercial leadership. When & where: Sleepy Hollow, NY for 4 days a week with travel on occasion Discover your role: Support the development and evolution of the global LCM strategy for brand (e.g., assess commercial opportunity across future indications, indication sequencing and prioritization, and geographic expansion) to maximize long-term brand value Lead the integration of future indication strategies into global brand planning, ensuring alignment with clinical development filing plans and contributing to a holistic, consistent commercial narrative for the program across lifecycle stages Partner with Global Hematology Marketing leadership and cross-functional teams (Clinical, Regulatory, Market Access) to contribute to asset strategy and ensure alignment with US and International teams Maintain an informed, forward-looking view of the multiple myeloma and broader hematology landscape, including TCEs, CAR-Ts, and emerging modalities such as CELMoDs, as well as support assessment of implications for the brands positioning and lifecycle strategy Synthesize competitive intelligence and evolving treatment trends into actionable insights and recommendations to inform lifecycle planning and future clinical development considerations Support the Brand Team in representing the commercial perspective for the product in cross-functional governance forums and key decision-making discussions This role requires: Bachelor's Degree Required, PhD, PharmD or MBA preferred 12 years of life sciences related experience with a focus on Marketing, Sales and/or Commercial Demonstrated ability to lead strategically, drive performance, build alignment, and collaborate across complex organizations Strong knowledge of hematology/oncology, particularly multiple myeloma and evolving treatment paradigms (e.g., TCEs, CAR-T, CELMoDs) Proven analytical skills, both quantitative and qualitative, with ability to synthesize diverse inputs (clinical, commercial, customer, competitive) into actionable strategies Prior experience supporting inline products and/or new indication launches required Experience in global or US marketing, including pre-approval planning for specialty oncology products Strong analytical and business insight with experience building strategic cases Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits. Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support benefits. For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process. If you have any questions, please speak with your recruiter. Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on‑site. Please speak with your recruiter and hiring manager for more information about on‑site expectations for your role and location. As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications. For jobs in

Canada:

this posting is for an existing position. Salary Range (annually) $183,100.00 - $305,200.00 Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases. Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company's Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.